SC Filed 2023-10-26 Event — SEC 0001193125-23-264081 →

Frazier Life Sciences VIII, L.P. → Arcutis Biotherapeutics, Inc. ARQT

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 11.11

16,801,149 shares short · +6.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $12.35M

Point72 Asset Mgmt

Other 13D/G Filings on Arcutis Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2022-06-28	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-05-12	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-02-09	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-02-09	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-02-08	SC	Bain Capital Life Sciences Fund, L.P.	—	—	view →
2020-10-07	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Frazier Life Sciences VIII, L.P.

Filed	Form	Issuer	Stake	Shares
2022-02-15	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2021-09-21	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2021-05-12	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2021-05-04	SC	Aptinyx Inc.	—	—	view →
2021-02-09	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2021-02-04	SC	Aptinyx Inc.	—	—	view →
2020-04-29	SC	Sierra Oncology, Inc.	—	—	view →
2020-03-23	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2020-01-16	SC	Aptinyx Inc.	—	—	view →
2020-01-13	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-01-23	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →